Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1995 1
1996 1
1997 2
1998 1
2000 2
2001 1
2003 1
2004 1
2005 1
2006 3
2007 4
2008 5
2009 2
2010 5
2011 3
2012 5
2013 4
2014 5
2015 3
2016 1
2017 3
2018 5
2019 4
2020 1
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
Genovese MC, Kalunian K, Gottenberg JE, Mozaffarian N, Bartok B, Matzkies F, Gao J, Guo Y, Tasset C, Sundy JS, de Vlam K, Walker D, Takeuchi T. Genovese MC, et al. Among authors: sundy js. JAMA. 2019 Jul 23;322(4):315-325. doi: 10.1001/jama.2019.9055. JAMA. 2019. PMID: 31334793 Free PMC article. Clinical Trial.
2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ. Neogi T, et al. Among authors: sundy js. Ann Rheum Dis. 2015 Oct;74(10):1789-98. doi: 10.1136/annrheumdis-2015-208237. Ann Rheum Dis. 2015. PMID: 26359487 Free PMC article.
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Combe B, Kivitz A, Tanaka Y, van der Heijde D, Simon JA, Baraf HSB, Kumar U, Matzkies F, Bartok B, Ye L, Guo Y, Tasset C, Sundy JS, Jahreis A, Genovese MC, Mozaffarian N, Landewé RBM, Bae SC, Keystone EC, Nash P. Combe B, et al. Among authors: sundy js. Ann Rheum Dis. 2021 Jul;80(7):848-858. doi: 10.1136/annrheumdis-2020-219214. Epub 2021 Jan 27. Ann Rheum Dis. 2021. PMID: 33504485 Free PMC article. Clinical Trial.
2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ. Neogi T, et al. Among authors: sundy js. Arthritis Rheumatol. 2015 Oct;67(10):2557-68. doi: 10.1002/art.39254. Arthritis Rheumatol. 2015. PMID: 26352873 Free PMC article.
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial.
Westhovens R, Rigby WFC, van der Heijde D, Ching DWT, Stohl W, Kay J, Chopra A, Bartok B, Matzkies F, Yin Z, Guo Y, Tasset C, Sundy JS, Jahreis A, Mozaffarian N, Messina OD, Landewé RB, Atsumi T, Burmester GR. Westhovens R, et al. Among authors: sundy js. Ann Rheum Dis. 2021 Jan 15;80(6):727-38. doi: 10.1136/annrheumdis-2020-219213. Online ahead of print. Ann Rheum Dis. 2021. PMID: 33452004 Free PMC article.
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
Kavanaugh A, Westhovens RR, Winthrop KL, Lee SJ, Tan Y, An D, Ye L, Sundy JS, Besuyen R, Meuleners L, Stanislavchuk M, Spindler AJ, Greenwald M, Alten R, Genovese MC. Kavanaugh A, et al. Among authors: sundy js. J Rheumatol. 2021 Aug;48(8):1230-1238. doi: 10.3899/jrheum.201183. Epub 2021 Feb 1. J Rheumatol. 2021. PMID: 33526618 Free article. Clinical Trial.
The rheumatology of gout.
Sundy JS. Sundy JS. Adv Chronic Kidney Dis. 2012 Nov;19(6):404-12. doi: 10.1053/j.ackd.2012.07.012. Adv Chronic Kidney Dis. 2012. PMID: 23089276 Review.
Progress in the pharmacotherapy of gout.
Sundy JS. Sundy JS. Curr Opin Rheumatol. 2010 Mar;22(2):188-93. doi: 10.1097/BOR.0b013e3283369014. Curr Opin Rheumatol. 2010. PMID: 20110792 Review.
Pegloticase for treating refractory chronic gout.
George RL Jr, Sundy JS. George RL Jr, et al. Among authors: sundy js. Drugs Today (Barc). 2012 Jul;48(7):441-9. doi: 10.1358/dot.2012.48.7.1813475. Drugs Today (Barc). 2012. PMID: 22844655 Review.
Update on nonsteriodal anti-inflammatory drugs.
Ardoin SP, Sundy JS. Ardoin SP, et al. Among authors: sundy js. Curr Opin Rheumatol. 2006 May;18(3):221-6. doi: 10.1097/01.bor.0000218940.04613.cc. Curr Opin Rheumatol. 2006. PMID: 16582683 Review.
67 results